Important: GHK-Cu is a research compound and is not FDA-approved
Autoimmun Rev (2014) 13(4-5):3917
Long-Lasting Supply: Ideal for regular supplementation
It took a lot of studying, but I eventually spent more than a million dollars on hacking my own biology, and Ive lost the weight
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Treatment duration and dose are based on clinical studies cited and discussed in this review, and are generally indicative of effective dose and time to see a significant clinical response